Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery
Clinical trial NCT00738361 · COMPLETED
Trial details
- NCT number
- NCT00738361
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2012-07-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.